期刊文献+

高效液相色谱法和荧光偏振免疫法检测血清万古霉素浓度的比较 被引量:8

Correlated research of detection for serum vancomycin concentrations between high performance liquid chromatography and fluorescence polarization immunoassay
暂未订购
导出
摘要 目的比较高效液相色谱(HPLC)和荧光偏振免疫(FPIA)测定血清万古霉素浓度方法的相关性。方法 30例患者的血清分别用HPLC和FPIA测定万古霉素浓度,对结果进行相关性分析。结果 HPLC测得万古霉素浓度为(30.04±14.02)μg/ml,FPIA测得值为(29.67±13.96)μg/ml,两种方法差值均值为(0.37±1.46)μg/ml,两种方法的线性相关系数r=0.9905。结论两种方法测定血清万古霉素药物浓度结果一致。 Objective The consistency of the results of serum vancomycin concentration the high-performance liquid chromatography(HPLC) and fluorescence polarization immunoassay(FPIA) were studied.Methods Serum vancomycin concentrations for 30 patients were measured by HPLC and FPIA. Correlation of results were analysised.Results Means for HPLC and standard deviation(SD) were(30.04±14.02) μg/ml. For FPIA,(29.67±13.96) μg/ml.The difference between the two methods' means were(0.37±1.46) μg/ml.The correlation coeffi cient of the two methods was 0.9905. Conclusion Measured serum vancomycin concentration results were consistent with each other.
出处 《空军医学杂志》 2013年第4期209-211,共3页 Medical Journal of Air Force
关键词 高效液相色谱法 荧光偏振免疫法 万古霉素 血药浓度 High per for mance liquid ch romatog raphy Fluorescence polar ization immunoassay Vancomycin Serum drug concentration
  • 相关文献

参考文献9

二级参考文献22

  • 1施毅.美国胸科学会医院获得性肺炎最新诊治指南给我们的启示[J].中国呼吸与危重监护杂志,2005,4(4):248-249. 被引量:198
  • 2孙健,卢岩,凌春燕,葛卫红.我院万古霉素应用的合理性分析[J].中国药房,2006,17(10):757-758. 被引量:13
  • 3祝文兵,阳利龙,何周康.高效液相色谱法测定血浆中万古霉素的浓度[J].药物分析杂志,2006,26(8):1106-1108. 被引量:12
  • 4涂厉标,王真,李旭梅.高效液相色谱法测定血清去甲万古霉素与万古霉素浓度[J].医药导报,2007,26(5):485-487. 被引量:17
  • 5戴自,刘裕昆,汪复,等.实用抗菌药物学[M].2版,上海:上海科学技术出版社,1998:222.
  • 6Hu MW,Anne L,Forni T,et al.Measurement of vancomycin on renally impaired patient samples using a new high-performance liquid chromatography method with vitamin B12 internal standard;comparison of high-performance liuid chromatography,emit,and fluorescence polarization immunoassay methods[J].Therapeutic Drug Monit,1990,12(6):562-565.
  • 7Jusus Valle MJ, Lopez FG, Navarro AS. Development and validation of an HPLC method for vancomycin application to a pharmacokinetic study [J]. J Pharm Biomed Anal, 2008, 48 (3) : 835-839.
  • 8Vance K, Rotschafer JC, Gilliland SS, et al. A comparative assessment of vancomycin associated nephrotoxicity in the young versus the elderly hospitalized patient[J]. J Antimicrob Chemother, 1994, 33(4): 811.
  • 9Rybak MJ, Albrecht LM, Boike SC, et al. Nephrotoxicity of vancomycin, alone and with an aminoglycoside[J], J Antimicrob Chemother, 1990, 25(4): 679.
  • 10Welty TE, Copa AK. Impact of vancomycin therapeutic drug monitoring on patient care[J]. Ann Pharmacother, 1994, 28(12): 1335.

共引文献61

同被引文献74

引证文献8

二级引证文献40

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部